Lumosa Therapeutics Co., Ltd. (TPEX:6535)
125.00
-3.50 (-2.72%)
Apr 24, 2026, 1:30 PM CST
-21.14% (1Y)
| Market Cap | 20.94B -37.4% |
| Revenue (ttm) | 35.83M -8.5% |
| Net Income | -340.54M |
| EPS | -2.05 |
| Shares Out | 167.49M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 252,364 |
| Average Volume | 199,138 |
| Open | 130.00 |
| Previous Close | 128.50 |
| Day's Range | 123.00 - 130.00 |
| 52-Week Range | 122.00 - 329.50 |
| Beta | 0.22 |
| RSI | 29.14 |
| Earnings Date | May 11, 2026 |